Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with
increased in-hospital mortality and worse clinical evolution, raising concerns towards …

We report the nationwide experience with solid organ transplant (SOT) and hematopoietic
stem cell transplant (HSCT) recipients diagnosed with coronavirus disease 2019 (COVID …

The coronavirus disease 2019 (COVID-19) pandemic has posed a significant challenge to
physicians and healthcare systems worldwide. Evidence about kidney transplant (KTx) …

There are limited data describing COVID‐19 in lung transplant recipients. We performed a
single center, retrospective case series study of lung transplant patients followed by the …

Background: Organ transplant recipients are vulnerable to multiple infectious agents and in
a world with a circulating SARS-CoV-2 virus, it would be expected that patients who are …

The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of
debate. We here describe the course and the outcome of COVID-19 in a cohort of patients …

Background and Objectives: In the era of the coronavirus disease 2019 (COVID-19)
pandemic, the management of immunosuppressive (IS) therapy in kidney transplant (KT) …

Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

Background. Patients with chronic kidney disease stage 5 and those on immunosuppression
are particularly vulnerable and are shielded as per public health strategy. We present our …